179 related articles for article (PubMed ID: 26827394)
21. Patient access to unapproved therapies: the leading edge of medicine and law.
Romano LV; Jacobson PD
J Health Life Sci Law; 2009 Jan; 2(2):45, 47-72. PubMed ID: 19288888
[TBL] [Abstract][Full Text] [Related]
22. Cancer and the constitution--choice at life's end.
Annas GJ
N Engl J Med; 2007 Jul; 357(4):408-13. PubMed ID: 17652658
[No Abstract] [Full Text] [Related]
23. A study in futility: Abigail Alliance for Better Access to Developmental Drugs will not expand access to experimental drugs for the terminally ill.
Ochs A
Seton Hall Law Rev; 2009; 39(2):559-603. PubMed ID: 19462540
[No Abstract] [Full Text] [Related]
24. Food and Drug Administration responds to pressure for expanded drug access.
Brower V
J Natl Cancer Inst; 2014 Jun; 106(6):dju171. PubMed ID: 24907387
[No Abstract] [Full Text] [Related]
25. United States laws and the rights of the terminally ill.
Cowan DH
Med Law; 2009 Sep; 28(3):519-29. PubMed ID: 20157966
[TBL] [Abstract][Full Text] [Related]
26. Expanded Access to Investigational Drugs: What Physicians and the Public Need to Know about FDA and Corporate Processes.
Finkelstein PE
AMA J Ethics; 2015 Dec; 17(12):1142-6. PubMed ID: 26698587
[No Abstract] [Full Text] [Related]
27. Principled compassion.
Nat Med; 2014 Dec; 20(12):1355. PubMed ID: 25473904
[TBL] [Abstract][Full Text] [Related]
28. Respiratory controversies in the critical care setting. When caring for critically ill patients, do clinicians have a responsibility to be innovative and try unproven approaches when accepted approaches are failing?
Rubin BK; Steinberg KP
Respir Care; 2007 Apr; 52(4):408-15. PubMed ID: 17417975
[TBL] [Abstract][Full Text] [Related]
29. Drugs on demand.
Nature; 2015 Nov; 527(7579):410. PubMed ID: 26607505
[No Abstract] [Full Text] [Related]
30. [Palliative sedation].
Mørch MM; Sjøgren P
Ugeskr Laeger; 2002 Jan; 164(4):472-3. PubMed ID: 11838415
[No Abstract] [Full Text] [Related]
31. Access to Investigational Drugs: FDA Expanded Access Programs or "Right-to-Try" Legislation?
Holbein ME; Berglund JP; Weatherwax K; Gerber DE; Adamo JE
Clin Transl Sci; 2015 Oct; 8(5):526-32. PubMed ID: 25588691
[TBL] [Abstract][Full Text] [Related]
32. One Last Shot.
Berlin J
Tex Med; 2016 Jul; 112(7):33-8. PubMed ID: 27441422
[TBL] [Abstract][Full Text] [Related]
33. Attorneys aim to reform "compassionate use": groups say the regulatory system lags behind scientific advances.
Printz C
Cancer; 2015 Jan; 121(2):163-4. PubMed ID: 25581115
[No Abstract] [Full Text] [Related]
34. Right-to-try laws and individual patient "compassionate use" of experimental oncology medications: A call for improved provider-patient communication.
Hoerger M
Death Stud; 2016; 40(2):113-20. PubMed ID: 26313583
[TBL] [Abstract][Full Text] [Related]
35. Stem Cell Businesses and Right to Try Laws.
Sipp D; Turner L; Rasko JEJ
Cell Stem Cell; 2019 Sep; 25(3):304-305. PubMed ID: 31491393
[No Abstract] [Full Text] [Related]
36. FDA's proposed regulations to expand access to investigational drugs for treatment use: the status quo in the guise of reform.
Rossen BR
Food Drug Law J; 2009; 64(1):183-223. PubMed ID: 19998746
[TBL] [Abstract][Full Text] [Related]
37. Is it sound public policy to let the terminally ill access experimental medical innovations?
Caplan A
Am J Bioeth; 2007 Jun; 7(6):1-3. PubMed ID: 17558976
[No Abstract] [Full Text] [Related]
38. [Food withdrawal to help and let die?].
Nau JY
Rev Med Suisse; 2015 Mar; 11(467):746-7. PubMed ID: 26027211
[No Abstract] [Full Text] [Related]
39. Recent developments in health law.
Lee WB; Shachar C; Chang P
J Law Med Ethics; 2008; 36(1):191-9. PubMed ID: 18315772
[No Abstract] [Full Text] [Related]
40. The right to information--a first step toward improving end-of-life care.
Blinderman CD; Prager K
J Pain Symptom Manage; 2011 May; 41(5):e1-2. PubMed ID: 21444185
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
